Oscar Pistorius and the International Paralympic Committee (IPC) are to meet to discuss concerns over regulations governing running prostheses after the South African apologised for the timing of his criticism of Brazilian rival Alan Oliveira.

Pistorius, whose own blades was subject to stringent testing in 2008 as he sought to compete in the Olympic Games, had a short meeting with the IPC after venting his fury at them for failing to act over the length of some athletes’ blades after Oliveira came from way back to pip him at the line in the men’s T44 200metres at the London 2012 Olympic Stadium Sunday night.

The Brazilian took the gold medal in 21.45 seconds, leaving race favourite Pistorius to settle for the silver, coming home in 21.52 seconds with stunned quiet from the 80,000 spectators greeting the result at the stadium.

Speaking overnight, IPC communications director Craig Spence said: “We’ve agreed we will meet again with our science and medical director, Peter van de Vliet, for Oscar to share his concerns with the IPC without the emotions of Sunday’s race.

“That meeting will be set up in due course. Oscar shared his concerns with us. We will meet to discuss what he’s got to say.”

Pistorius, who ran in the 400m at the Olympics, first won the 200m Paralympic title in Athens, successfully defended it in Beijing and set a world record of 21.30 in Saturday’s heats before finishing second in the final.

Pistorius, 25, is next set to be in action in the 100m heats tomorrow. Any changes made to his blades would be subject to intense scrutiny.

The South African took the International Association of Athletics Federations (IAAF) to the Court of Arbitration for Sport (CAS) in 2008, challenging their assertion his blades caused an unfair advantage.

Meanwhile, the IPC de-fended their procedures and insisted all eight athletes were subject to testing prior to Sunday night’s final.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.